{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:24:16Z","timestamp":1791465856841,"version":"4.3.4"},"reference-count":201,"publisher":"Rockefeller University Press","issue":"4","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI088364"],"award-info":[{"award-number":["R01AI088364"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI095983"],"award-info":[{"award-number":["R01AI095983"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127564"],"award-info":[{"award-number":["R01AI127564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI163029"],"award-info":[{"award-number":["R01AI163029"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical and Translational Science Awards","award":["UL1 TR001866"],"award-info":[{"award-number":["UL1 TR001866"]}]},{"DOI":"10.13039\/100001621","name":"Fisher Center for Alzheimer\u2019s Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005162","name":"Meyer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-10-IAHU-01"],"award-info":[{"award-number":["ANR-10-IAHU-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence","award":["ANR-10-LABX-62-IBEID"],"award-info":[{"award-number":["ANR-10-LABX-62-IBEID"]}]},{"name":"French Foundation for Medical Research","award":["EQU201903007798"],"award-info":[{"award-number":["EQU201903007798"]}]},{"name":"ECOS-Nord","award":["C19S0163407"],"award-info":[{"award-number":["C19S0163407"]}]},{"name":"Agence nationale de recherches sur le sida et les h\u00e9patites virales Nord-Sud","award":["ANRS-COV05"],"award-info":[{"award-number":["ANRS-COV05"]}]},{"name":"ANR GENVIR","award":["ANR-20-CE93-00"],"award-info":[{"award-number":["ANR-20-CE93-00"]}]},{"name":"ANR AABIFNCOV","award":["ANR-20-CO11-0001"],"award-info":[{"award-number":["ANR-20-CO11-0001"]}]},{"name":"ANR GenMIS-C","award":["ANR-21-COVR-0039"],"award-info":[{"award-number":["ANR-21-COVR-0039"]}]},{"DOI":"10.13039\/501100002915","name":"Fondation Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EA20170638020"],"award-info":[{"award-number":["EA20170638020"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007492","name":"Fondation Bettencourt Schueller","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002350","name":"St. Giles Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["824110"],"award-info":[{"award-number":["824110"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Square Foundation"},{"name":"Grandir\u2013Fonds de solidarit\u00e9 pour l\u2019Enfance"},{"DOI":"10.13039\/100012019","name":"Fondation du Souffle","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019631","name":"SCOR Corporate Foundation for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Ministry of Higher Education, Research, and Innovation","award":["MESRI-COVID-19"],"award-info":[{"award-number":["MESRI-COVID-19"]}]},{"name":"REACTing-INSERM"},{"DOI":"10.13039\/501100021716","name":"University of Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,4]]},"abstract":"<jats:p>The vast interindividual clinical variability observed in any microbial infection\u2014ranging from silent infection to lethal disease\u2014is increasingly being explained by human genetic and immunological determinants. Autoantibodies neutralizing specific cytokines underlie the same infectious diseases as inborn errors of the corresponding cytokine or response pathway. Autoantibodies against type I IFNs underlie COVID-19 pneumonia and adverse reactions to the live attenuated yellow fever virus vaccine. Autoantibodies against type II IFN underlie severe disease caused by environmental or tuberculous mycobacteria, and other intra-macrophagic microbes. Autoantibodies against IL-17A\/F and IL-6 are less common and underlie mucocutaneous candidiasis and staphylococcal diseases, respectively. Inborn errors of and autoantibodies against GM-CSF underlie pulmonary alveolar proteinosis; associated infections are less well characterized. In individual patients, autoantibodies against cytokines preexist infection with the pathogen concerned and underlie the infectious disease. Human antibody-driven autoimmunity can interfere with cytokines that are essential for protective immunity to specific infectious agents but that are otherwise redundant, thereby underlying specific infectious diseases.<\/jats:p>","DOI":"10.1084\/jem.20211387","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T02:22:36Z","timestamp":1646792556000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":124,"title":["Human autoantibodies underlying infectious diseases"],"prefix":"10.1084","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2603-0323","authenticated-orcid":true,"given":"Anne","family":"Puel","sequence":"first","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale, Necker Hospital for Sick Children, Paris, France 1"},{"name":"Imagine Institute, Paris Cit\u00e9 University, Paris, France 2"},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-8437","authenticated-orcid":true,"given":"Paul","family":"Bastard","sequence":"additional","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale, Necker Hospital for Sick Children, Paris, France 1"},{"name":"Imagine Institute, Paris Cit\u00e9 University, Paris, France 2"},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 3"},{"name":"4Department of Pediatrics, Necker Hospital for Sick Children, Assistance Publique \u2013 H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-2482","authenticated-orcid":true,"given":"Jacinta","family":"Bustamante","sequence":"additional","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale, Necker Hospital for Sick Children, Paris, France 1"},{"name":"Imagine Institute, Paris Cit\u00e9 University, Paris, France 2"},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 3"},{"name":"5Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique \u2013 H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-4169","authenticated-orcid":true,"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale, Necker Hospital for Sick Children, Paris, France 1"},{"name":"Imagine Institute, Paris Cit\u00e9 University, Paris, France 2"},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 3"},{"name":"4Department of Pediatrics, Necker Hospital for Sick Children, Assistance Publique \u2013 H\u00f4pitaux de Paris, Paris, France"},{"name":"6Howard Hughes Medical Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"2023072616533737700_bib1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/imcb.12495","article-title":"Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19","volume":"99","author":"Abers","year":"2021","journal-title":"Immunol. Cell Biol."},{"key":"2023072616533737700_bib2","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.jaut.2021.102598","article-title":"COVID-19 convalescent plasma composition and immunological effects in severe patients","volume":"118","author":"Acosta-Ampudia","year":"2021","journal-title":"J. Autoimmun."},{"key":"2023072616533737700_bib3","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001465","article-title":"Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)","volume":"7","author":"Aletaha","year":"2021","journal-title":"RMD Open"},{"key":"2023072616533737700_bib4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213179","article-title":"Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association","volume":"14","author":"Anderson","year":"2019","journal-title":"PLoS One"},{"key":"2023072616533737700_bib5","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02733-18","article-title":"Cryptococcus deuterogattii VGIIa infection associated with travel to the pacific northwest outbreak region in an anti-granulocyte-macrophage colony-stimulating factor autoantibody-positive patient in the United States","volume":"10","author":"Applen Clancey","year":"2019","journal-title":"mBio"},{"key":"2023072616533737700_bib6","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.2169\/internalmedicine.54.5034","article-title":"Autoimmune pulmonary alveolar proteinosis following pulmonary aspergillosis","volume":"54","author":"Arai","year":"2015","journal-title":"Intern. Med."},{"key":"2023072616533737700_bib7","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci. Immunol."},{"key":"2023072616533737700_bib8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202592","article-title":"Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance","volume":"218","author":"Asano","year":"2021","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib9","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1073\/pnas.1704259114","article-title":"Severe viral respiratory infections in children with IFIH1 loss-of-function mutations","volume":"114","author":"Asgari","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072616533737700_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"key":"2023072616533737700_bib11","doi-asserted-by":"publisher","DOI":"10.1172\/jci139980","article-title":"Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency","volume":"131","author":"Bastard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210554","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib14","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"2023072616533737700_bib15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40618-020s4001323-4","article-title":"A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in lombardy, Italy: Letter to the editor","volume":"43","author":"Beccuti","year":"2020","journal-title":"J. Endocrinol. Invest."},{"key":"2023072616533737700_bib16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.abe7591","article-title":"Susceptibility to severe COVID-19","volume":"370","author":"Beck","year":"2020","journal-title":"Science"},{"key":"2023072616533737700_bib17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2004.03.013","article-title":"Characterization of the immunoreactivity of anti-interferon alpha antibodies in myasthenia gravis patients. Epitope mapping","volume":"23","author":"Bello-Rivero","year":"2004","journal-title":"J. Autoimmun."},{"key":"2023072616533737700_bib18","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"Beziat","year":"2018","journal-title":"Sci. Immunol."},{"key":"2023072616533737700_bib19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191804","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Beziat","year":"2020","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.coi.2021.06.013","article-title":"Monogenic autoimmunity and infectious diseases: The double-edged sword of immune dysregulation","volume":"72","author":"Bigley","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib21","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3389\/fimmu.2019.02629","article-title":"Anti-IL6 autoantibodies in an infant with CRP-less septic shock","volume":"10","author":"Bloomfield","year":"2019","journal-title":"Front. Immunol."},{"key":"2023072616533737700_bib22","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000226","article-title":"Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-gamma monoclonal antibody, in SLE subjects without or with lupus nephritis","volume":"4","author":"Boedigheimer","year":"2017","journal-title":"Lupus Sci. Med."},{"key":"2023072616533737700_bib23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.coi.2021.07.001","article-title":"Mycobacterial diseases in patients with inborn errors of immunity","volume":"72","author":"Boisson-Dupuis","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020s1000758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev-immunol-032713-120222","article-title":"Anticytokine autoantibody-associated immunodeficiency","volume":"32","author":"Browne","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"2023072616533737700_bib26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/ACI.0b013e3283402b41","article-title":"Immunodeficiency secondary to anticytokine autoantibodies","volume":"10","author":"Browne","year":"2010","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"2023072616533737700_bib28","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1182\/blood-2011b12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"2023072616533737700_bib29","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00439-020s0002120-y","article-title":"Mendelian susceptibility to mycobacterial disease: Recent discoveries","volume":"139","author":"Bustamante","year":"2020","journal-title":"Hum. Genet."},{"key":"2023072616533737700_bib30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj7521","article-title":"Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort","volume":"14","author":"Carapito","year":"2022","journal-title":"Sci. Transl Med."},{"key":"2023072616533737700_bib31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/genes12020169","article-title":"Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in two siblings: Same mutations but very different phenotypes","volume":"12","author":"Carpino","year":"2021","journal-title":"Genes (Basel)"},{"key":"2023072616533737700_bib32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00439-020s0002184-w","article-title":"The human genetic determinism of life-threatening infectious diseases: Genetic heterogeneity and physiological homogeneity?","volume":"139","author":"Casanova","year":"2020","journal-title":"Hum. Genet."},{"key":"2023072616533737700_bib33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-pathol-031920-101429","article-title":"Lethal infectious diseases as inborn errors of immunity: Toward a synthesis of the germ and genetic theories","volume":"16","author":"Casanova","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"2023072616533737700_bib34","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1126\/science.abj7965","article-title":"Mechanisms of viral inflammation and disease in humans","volume":"374","author":"Casanova","year":"2021","journal-title":"Science"},{"key":"2023072616533737700_bib35","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat. Commun."},{"key":"2023072616533737700_bib36","first-page":"1","article-title":"Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital","author":"Chauvineau-Grenier","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.coi.2021.04.007","article-title":"Inborn errors of IL-6 family cytokine responses","volume":"72","author":"Chen","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jaci.2021.02.044","article-title":"Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome","volume":"148","author":"Chen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023072616533737700_bib39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-immunol-020711-074953","article-title":"Monogenic autoimmunity","volume":"30","author":"Cheng","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"2023072616533737700_bib40","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2012b08-452482","article-title":"Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"key":"2023072616533737700_bib41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-gamma autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2023072616533737700_bib42","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s10875-018s1080539-2","article-title":"Inherited CARD9 deficiency: Invasive disease caused by ascomycete fungi in previously healthy children and adults","volume":"38","author":"Corvilain","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib43","doi-asserted-by":"publisher","first-page":"ofx211","DOI":"10.1093\/ofid\/ofx211","article-title":"Autoantibodies to granulocyte-macrophage colony-stimulating factor Associated with severe and unusual manifestations of Cryptococcus gattii infections","volume":"4","author":"Crum-Cianflone","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"2023072616533737700_bib44","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-gamma autoantibody","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"2023072616533737700_bib45","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1084\/jem.20080321","article-title":"Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells","volume":"205","author":"de Beaucoudrey","year":"2008","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10875-021-00994-9","article-title":"Plasma exchange to rescue patients with autoantibodies against type I interferons and life-threatening COVID-19 pneumonia","volume":"41","author":"de Prost","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib47","doi-asserted-by":"publisher","first-page":"bcr2017222940","DOI":"10.1136\/bcr-2017-222940","article-title":"Pulmonary alveolar proteinosis following cryptococcal meningitis: A possible cause?","volume":"2018","author":"Demir","year":"2018","journal-title":"BMJ Case Rep."},{"key":"2023072616533737700_bib48","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1172\/jci119758","article-title":"Human pulmonary alveolar proteinosis associated with a defect in GM-CSF\/IL-3\/IL-5 receptor common beta chain expression","volume":"100","author":"Dirksen","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib49","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"2023072616533737700_bib50","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1172\/jci2901","article-title":"Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection","volume":"101","author":"Dorman","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib51","doi-asserted-by":"publisher","first-page":"307ra154","DOI":"10.1126\/scitranslmed.aac4227","article-title":"Human IFNAR2 deficiency: Lessons for antiviral immunity","volume":"7","author":"Duncan","year":"2015","journal-title":"Sci. Transl Med."},{"key":"2023072616533737700_bib52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tig.2020.08.017","article-title":"Genetic lesions of type I interferon signalling in human antiviral immunity","volume":"37","author":"Duncan","year":"2021","journal-title":"Trends Genet."},{"key":"2023072616533737700_bib53","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"3","author":"Frey-Jakobs","year":"2018","journal-title":"Sci. Immunol."},{"key":"2023072616533737700_bib54","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"2023072616533737700_bib55","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1327","article-title":"Antibodies against type I interferon: Detection and association with severe clinical outcome in COVID-19 patients","volume":"10","author":"Goncalves","year":"2021","journal-title":"Clin. Transl Immunol."},{"key":"2023072616533737700_bib56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190502","article-title":"Anti-IFN-gamma autoantibodies underlie disseminated Talaromyces marneffei infections","volume":"217","author":"Guo","year":"2020","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib57","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/art.39607","article-title":"Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: A comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases","volume":"68","author":"Gupta","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"2023072616533737700_bib58","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072616533737700_bib59","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1084\/jem.20182295","article-title":"Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines","volume":"216","author":"Hernandez","year":"2019","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib60","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1084\/jem.20180628","article-title":"Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency","volume":"215","author":"Hernandez","year":"2018","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cytogfr.2013.04.002","article-title":"Fine tuning type I interferon responses","volume":"24","author":"Hertzog","year":"2013","journal-title":"Cytokine Growth Factor. Rev."},{"key":"2023072616533737700_bib62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2003blo04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"Hoflich","year":"2004","journal-title":"Blood"},{"key":"2023072616533737700_bib63","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/nejmoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib64","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/gut.2005.079392","article-title":"Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn\u2019s disease","volume":"55","author":"Hommes","year":"2006","journal-title":"Gut"},{"key":"2023072616533737700_bib65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-gamma autoantibody-associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"2023072616533737700_bib66","first-page":"79","article-title":"Autoimmunity in a rural community","volume":"12","author":"Hooper","year":"1972","journal-title":"Clin. Exp. Immunol."},{"key":"2023072616533737700_bib67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/jpids\/piy100","article-title":"Unusual presentation of severe endobronchial obstruction caused by Cryptococcus gattii in a child","volume":"9","author":"Huynh","year":"2020","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"2023072616533737700_bib68","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/jir.1987.7.429","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"2023072616533737700_bib69","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1098\/rspb.1957.0049","article-title":"Virus interference. II. Some properties of interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"2023072616533737700_bib70","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1056\/nejm199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s15010-010s1500067-3","article-title":"Anti-interferon-gamma autoantibody and opportunistic infections: Case series and review of the literature","volume":"39","author":"Kampitak","year":"2011","journal-title":"Infection"},{"key":"2023072616533737700_bib72","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coi.2014.01.015","article-title":"STAT3 is a central regulator of lymphocyte differentiation and function","volume":"28","author":"Kane","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib74","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1172\/JCI135460","article-title":"Inherited human IFN-gamma deficiency underlies mycobacterial disease","volume":"130","author":"Kerner","year":"2020","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib75","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"2023072616533737700_bib76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cyto.2014.01.005","article-title":"Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria","volume":"66","author":"Kim","year":"2014","journal-title":"Cytokine"},{"key":"2023072616533737700_bib77","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib78","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi6235","article-title":"Comment on \u201cAberrant type 1 immunity drives susceptibility to mucosal fungal infections\u201d","volume":"373","author":"Kisand","year":"2021","journal-title":"Science"},{"key":"2023072616533737700_bib79","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib80","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154886","article-title":"The intersection of COVID-19 and autoimmunity","volume":"131","author":"Knight","year":"2021","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib81","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s10875-017-0425-3","article-title":"Rituximab restores IFN-gamma-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with anti-interferon-gamma autoantibody","volume":"37","author":"Koizumi","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib82","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00134-021-06392-4","article-title":"Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients","volume":"47","author":"Koning","year":"2021","journal-title":"Intensive Care Med."},{"key":"2023072616533737700_bib83","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1084\/jem.20140280","article-title":"Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome","volume":"212","author":"Kreins","year":"2015","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib84","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.1038\/s41598-019","article-title":"Functional neutralization of anti-IFN-gamma autoantibody in patients with nontuberculous mycobacteria infection","volume":"9","author":"Krisnawati","year":"2019","journal-title":"Sci. Rep."},{"key":"2023072616533737700_bib85","doi-asserted-by":"publisher","first-page":"1629258","DOI":"10.1155\/2019\/1629258","article-title":"Blockade effects of anti-interferon- (IFN-) gamma autoantibodies on IFN-gamma-regulated antimicrobial immunity","volume":"2019","author":"Krisnawati","year":"2019","journal-title":"J. Immunol. Res."},{"key":"2023072616533737700_bib86","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00439-020s0002180-0","article-title":"Autoantibodies against cytokines: Phenocopies of primary immunodeficiencies?","volume":"139","author":"Ku","year":"2020","journal-title":"Hum. Genet."},{"key":"2023072616533737700_bib87","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","article-title":"Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia","volume":"137","author":"Ku","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023072616533737700_bib88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10875-016s1080364-4","article-title":"Disseminated cryptococcosis due to anti-granulocyte-macrophage colony-stimulating factor autoantibodies in the absence of pulmonary alveolar proteinosis","volume":"37","author":"Kuo","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib89","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1084\/jem.20161759","article-title":"Recurrent rhinovirus infections in a child with inherited MDA5 deficiency","volume":"214","author":"Lamborn","year":"2017","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib90","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00439-020s0002137-3","article-title":"Genetic determinants of host immunity against human rhinovirus infections","volume":"139","author":"Lamborn","year":"2020","journal-title":"Hum. Genet."},{"key":"2023072616533737700_bib91","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"2023072616533737700_bib92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030292","article-title":"Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Levin","year":"2006","journal-title":"PLoS Med."},{"key":"2023072616533737700_bib93","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aax7965","article-title":"Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-beta","volume":"4","author":"Li","year":"2019","journal-title":"Sci. Immunol."},{"key":"2023072616533737700_bib94","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mib.2017.10.016","article-title":"Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals","volume":"40","author":"Li","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"2023072616533737700_bib95","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib96","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s10875-019s1000652-1","article-title":"Juvenile-onset immunodeficiency secondary to anti-interferon-gamma autoantibodies","volume":"39","author":"Liew","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib97","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1084\/jem.20181621","article-title":"Severe influenza pneumonitis in children with inherited TLR3 deficiency","volume":"216","author":"Lim","year":"2019","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib98","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nat. Med."},{"key":"2023072616533737700_bib99","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib100","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211211","article-title":"Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs","volume":"218","author":"Lopez","year":"2021","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib101","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib102","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20151467","article-title":"Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets","volume":"213","author":"Ma","year":"2016","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib103","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1084\/jem.20111680","article-title":"Evolutionary genetic dissection of human interferons","volume":"208","author":"Manry","year":"2011","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib104","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0042-6822(66)90126-7","article-title":"Molecular basis of interferon action: Inhibition of viral RNA translation","volume":"30","author":"Marcus","year":"1966","journal-title":"Virology"},{"key":"2023072616533737700_bib105","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1084\/jem.20080759","article-title":"Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1","volume":"205","author":"Martinez-Moczygemba","year":"2008","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030292","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med."},{"key":"2023072616533737700_bib107","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: Preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"2023072616533737700_bib108","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1","volume":"131","author":"Meisel","year":"2021","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib109","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"2023072616533737700_bib110","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/eji.202048793","article-title":"Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway","volume":"51","author":"Meyts","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"2023072616533737700_bib111","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"2023072616533737700_bib112","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1084\/jem.20082767","article-title":"Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome","volume":"206","author":"Minegishi","year":"2009","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib113","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"2023072616533737700_bib114","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007709","article-title":"Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma","volume":"6","author":"Molfino","year":"2016","journal-title":"BMJ Open"},{"key":"2023072616533737700_bib115","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/art.30399","article-title":"Association of endogenous anti-interferon-alpha autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus","volume":"63","author":"Morimoto","year":"2011","journal-title":"Arthritis Rheum."},{"key":"2023072616533737700_bib116","doi-asserted-by":"publisher","first-page":"a038414","DOI":"10.1101\/cshperspect.a038414","article-title":"Induction and evasion of type-I interferon responses during influenza A virus infection","volume":"11","author":"Munoz-Moreno","year":"2021","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"2023072616533737700_bib117","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","article-title":"Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985\u20132014","volume":"79","author":"Myasoedova","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"2023072616533737700_bib118","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jaci.2019.11.015","article-title":"Defining the biological responses of IL-6 by the study of a novel IL-6 receptor chain immunodeficiency","volume":"145","author":"Nahum","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023072616533737700_bib119","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/annrheumdis-2012-202768","article-title":"Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections","volume":"72","author":"Nanki","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"2023072616533737700_bib120","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib121","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/nejm199612263352602","article-title":"A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib122","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1038\/s41598-020","article-title":"Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA","volume":"10","author":"Nithichanon","year":"2020","journal-title":"Sci. Rep."},{"key":"2023072616533737700_bib123","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb1662","article-title":"Human inborn errors of immunity: An expanding universe","volume":"5","author":"Notarangelo","year":"2020","journal-title":"Sci. Immunol."},{"key":"2023072616533737700_bib124","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.immuni.2015.04.021","article-title":"Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases","volume":"42","author":"Oftedal","year":"2015","journal-title":"Immunity"},{"key":"2023072616533737700_bib125","doi-asserted-by":"publisher","first-page":"ofx082","DOI":"10.1093\/ofid\/ofx082","article-title":"Susceptibility to cryptococcal meningoencephalitis associated with idiopathic CD4+ lymphopenia and secondary germline or acquired defects","volume":"4","author":"Panackal","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"2023072616533737700_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.129.1.1","article-title":"Antibodies to alpha-interferon in a patient with systemic lupus erythematosus","volume":"129","author":"Panem","year":"1982","journal-title":"J. Immunol."},{"key":"2023072616533737700_bib127","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1158\/1055-9965.epi-14-0429","article-title":"Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women","volume":"23","author":"Parks","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2023072616533737700_bib128","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/pgmj.65.767.674","article-title":"Alveolar proteinosis and nocardiosis: A patient treated by bronchopulmonary lavage","volume":"65","author":"Pascual","year":"1989","journal-title":"Postgrad. Med. J."},{"key":"2023072616533737700_bib129","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"Patel","year":"2005","journal-title":"J. Immunol."},{"key":"2023072616533737700_bib130","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1182\/blood.2019004352","article-title":"Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia","volume":"136","author":"Patnaik","year":"2020","journal-title":"Blood"},{"key":"2023072616533737700_bib131","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/annrheumdis-2018-214367","article-title":"Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: A multidatabase cohort study","volume":"78","author":"Pawar","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"2023072616533737700_bib132","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10875-020s1000796-5","article-title":"Anti-GM-CSF autoantibodies and Cryptococcus neoformans var. grubii CNS vasculitis","volume":"40","author":"Perrineau","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib133","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/art.37824","article-title":"Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: A phase I randomized, controlled, dose-escalation study","volume":"65","author":"Petri","year":"2013","journal-title":"Arthritis Rheum."},{"key":"2023072616533737700_bib134","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.coi.2021.08.001","article-title":"Candidiasis in patients with APS-1: Low IL-17, high IFN-gamma, or both?","volume":"72","author":"Philippot","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128481","article-title":"HLA-DRB1 and HLA-DQB1 are associated with adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies","volume":"10","author":"Pithukpakorn","year":"2015","journal-title":"PLoS One"},{"key":"2023072616533737700_bib136","first-page":"544","article-title":"[Prevalence of autoantibodies in serum of healthy persons over 85 years of age]","volume":"52","author":"Potocka-Plazak","year":"1995","journal-title":"Przegl Lek"},{"key":"2023072616533737700_bib137","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/150.5.707","article-title":"Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease","volume":"150","author":"Pozzetto","year":"1984","journal-title":"J. Infect. Dis."},{"key":"2023072616533737700_bib138","doi-asserted-by":"publisher","first-page":"ofw093","DOI":"10.1093\/ofid\/ofw093","article-title":"Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies","volume":"3","author":"Pruetpongpun","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"2023072616533737700_bib139","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00439-020-02141-7","article-title":"Human inborn errors of immunity underlying superficial or invasive candidiasis","volume":"139","author":"Puel","year":"2020","journal-title":"Hum. Genet."},{"key":"2023072616533737700_bib140","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1084\/jem.20191002","article-title":"The nature of human IL-6","volume":"216","author":"Puel","year":"2019","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib141","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi5459","article-title":"Comment on \u201cAberrant type 1 immunity drives susceptibility to mucosal fungal infections\u201d","volume":"373","author":"Puel","year":"2021","journal-title":"Science"},{"key":"2023072616533737700_bib142","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"2023072616533737700_bib143","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/aci.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"2023072616533737700_bib144","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib145","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.coi.2010.06.009","article-title":"Inborn errors of mucocutaneous immunity to Candida albicans in humans: A role for IL-17 cytokines?","volume":"22","author":"Puel","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib146","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4049\/jimmunol.180.1.647","article-title":"Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6","volume":"180","author":"Puel","year":"2008","journal-title":"J. Immunol."},{"key":"2023072616533737700_bib147","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jinf.2012.03.020","article-title":"Opportunistic infections in patients with pulmonary alveolar proteinosis","volume":"65","author":"Punatar","year":"2012","journal-title":"J. Infect."},{"key":"2023072616533737700_bib148","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s10875-021s1001168-3","article-title":"Interferon-alpha2 auto-antibodies in convalescent plasma therapy for COVID-19","volume":"42","author":"Raadsen","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib149","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus secukinumab in plaque psoriasis","volume":"385","author":"Reich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib150","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gut.2005.079434","article-title":"A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn\u2019s disease","volume":"55","author":"Reinisch","year":"2006","journal-title":"Gut"},{"key":"2023072616533737700_bib151","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMc076367","article-title":"STAT3 mutation in the original patient with Job\u2019s syndrome","volume":"357","author":"Renner","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib152","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/inf.0b013e3181f6f78a","article-title":"Meningoencephalitis caused by varicella-zoster virus reactivation in a child with dominant partial interferon-gamma receptor-1 deficiency","volume":"30","author":"Roesler","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2023072616533737700_bib153","doi-asserted-by":"publisher","first-page":"a028415","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2023072616533737700_bib154","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2017.83","article-title":"The role of IL-6 in host defence against infections: Immunobiology and clinical implications","volume":"13","author":"Rose-John","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"2023072616533737700_bib155","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J. Immunol."},{"key":"2023072616533737700_bib156","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/cid\/ciu968","article-title":"Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated\/extrapulmonary nocardiosis","volume":"60","author":"Rosen","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"2023072616533737700_bib157","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fimmu.2018.00544","article-title":"Neutralizing anti-cytokine autoantibodies against interferon-alpha in immunodysregulation polyendocrinopathy enteropathy X-linked","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Front. Immunol."},{"key":"2023072616533737700_bib158","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1212\/wnl.50.5.1266","article-title":"Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)","volume":"50","author":"Rudick","year":"1998","journal-title":"Neurology"},{"key":"2023072616533737700_bib159","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"2023072616533737700_bib160","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41467-021","article-title":"Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis","volume":"12","author":"Sakaue","year":"2021","journal-title":"Nat. Commun."},{"key":"2023072616533737700_bib161","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv. Immunol."},{"key":"2023072616533737700_bib162","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib163","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1164\/rccm.2109105","article-title":"Pulmonary alveolar proteinosis: Progress in the first 44 years","volume":"166","author":"Seymour","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2023072616533737700_bib164","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"key":"2023072616533737700_bib165","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-gamma autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib166","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jiac.2013.08.003","article-title":"Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients","volume":"20","author":"Shima","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"2023072616533737700_bib167","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/intimm\/dxg088","article-title":"Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor","volume":"15","author":"Shiono","year":"2003","journal-title":"Int. Immunol."},{"key":"2023072616533737700_bib168","first-page":"259","article-title":"Incidence and titers of antinuclear, antismooth muscle, and other autoantibodies in blood donors","volume":"86","author":"Shu","year":"1975","journal-title":"J. Lab Clin. Med."},{"key":"2023072616533737700_bib169","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s10875-021s1001136-x","article-title":"Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in barcelona","volume":"41","author":"Solanich","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib170","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib171","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/imj.14637","article-title":"The significance of anti-granulocyte-macrophage colony-stimulating factor antibodies in cryptococcal infection: Case series and review of antibody testing","volume":"49","author":"Stevenson","year":"2019","journal-title":"Intern. Med. J."},{"key":"2023072616533737700_bib172","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1084\/jem.20080990","article-title":"Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA","volume":"205","author":"Suzuki","year":"2008","journal-title":"J. Exp. Med."},{"key":"2023072616533737700_bib173","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1164\/rccm.201002-0271OC","article-title":"Hereditary pulmonary alveolar proteinosis: Pathogenesis, presentation, diagnosis, and therapy","volume":"182","author":"Suzuki","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2023072616533737700_bib174","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1128\/CVI.00053-10","article-title":"Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon","volume":"17","author":"Tang","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"key":"2023072616533737700_bib175","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib176","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10875-021s1000980-1","article-title":"The ever-increasing array of novel inborn errors of immunity: An interim update by the IUIS committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib177","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-019","article-title":"Pulmonary alveolar proteinosis","volume":"5","author":"Trapnell","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2023072616533737700_bib178","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1056\/NEJMra023226","article-title":"Pulmonary alveolar proteinosis","volume":"349","author":"Trapnell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2023072616533737700_bib179","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s10875-021s1001036-0","article-title":"Neutralizing autoantibodies to type I IFNs in &gt;10% of patients with severe COVID-19 pneumonia hospitalized in madrid, Spain","volume":"41","author":"Troya","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib180","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021s1001051-1","article-title":"STAT3 hyper-IgE syndrome-an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib181","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000464","article-title":"Safety profile of anifrolumab in patients with active SLE: An integrated analysis of phase II and III trials","volume":"8","author":"Tummala","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"2023072616533737700_bib182","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-immunolan042718-041257","article-title":"Self-Awareness: Nucleic acid-driven inflammation and the type I interferonopathies","volume":"37","author":"Uggenti","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"2023072616533737700_bib183","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/289496a0","article-title":"Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon","volume":"289","author":"Vallbracht","year":"1981","journal-title":"Nature"},{"key":"2023072616533737700_bib184","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"2023072616533737700_bib185","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10875-021s1001060-0","article-title":"Neutralizing autoantibodies to type I interferons in COVID-19 convalescent donor plasma","volume":"41","author":"Vazquez","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib186","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s10875-021-01068-6","article-title":"Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-beta","volume":"41","author":"Vinh","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib187","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/myc.13247","article-title":"Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association","volume":"64","author":"Viola","year":"2021","journal-title":"Mycoses"},{"key":"2023072616533737700_bib188","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J. Clin. Invest."},{"key":"2023072616533737700_bib189","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021s4103631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2023072616533737700_bib190","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/art.39248","article-title":"Blockade of interferon-gamma normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus","volume":"67","author":"Welcher","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"2023072616533737700_bib191","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/1535370218764086","article-title":"Characterization of anti-interferon-gamma antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms","volume":"243","author":"Wipasa","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"2023072616533737700_bib192","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10875-013s1089938-6","article-title":"Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood","volume":"33","author":"Wolff","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"2023072616533737700_bib193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076371","article-title":"Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand","volume":"8","author":"Wongkulab","year":"2013","journal-title":"PLoS One"},{"key":"2023072616533737700_bib194","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","article-title":"Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against mycobacteria","volume":"183","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"2023072616533737700_bib195","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00439-019s0002108-3","article-title":"Human genetics of life-threatening influenza pneumonitis","volume":"139","author":"Zhang","year":"2020","journal-title":"Hum. Genet."},{"key":"2023072616533737700_bib196","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04447-0","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"2023072616533737700_bib197","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2023072616533737700_bib198","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00439-020s0002127-5","article-title":"Herpes simplex virus encephalitis of childhood: Inborn errors of central nervous system cell-intrinsic immunity","volume":"139","author":"Zhang","year":"2020","journal-title":"Hum. Genet."},{"key":"2023072616533737700_bib199","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"2023072616533737700_bib200","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.coi.2009.03.001","article-title":"Transcriptional regulatory networks in Th17 cell differentiation","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"2023072616533737700_bib201","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","article-title":"Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19","volume":"184","author":"Ziegler","year":"2021","journal-title":"Cell"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20211387\/1776685\/jem_20211387.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20211387\/1776685\/jem_20211387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T15:42:22Z","timestamp":1690386142000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/219\/4\/e20211387\/213087\/Human-autoantibodies-underlying-infectious"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":201,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,4]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20211387","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"article-number":"e20211387"}}